Crossover RCT in 30 adults with inactive lupus nephritis and residual proteinuria (21 analysed): adding dapagliflozin to standard care reduced proteinuria by 36.1% at 6 months v 3.5% without it; 33.3% reported hypotension symptoms.
RCTn = 30
Vajgel et al. Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial